MTLS Materialise NV - American Depositary Shares
NASDAQ · Technology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Apr 23, 2026MTLS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
MTLS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Materialise NV - American Depositary Shares Company overview from Wikipedia
Materialise NV, headquartered in Leuven, Belgium, is a company in the 3D printing / additive manufacturing sector.
History
1990s
Materialise was founded in June 1990 by Wilfried Vancraen and his wife Hilde Ingelaere as a Rapid Prototyping service bureau. It was the first company of its kind in the Benelux region of Europe, through the acquisition of a single Stereolithography machine (the SLA 1).
In 1992, Materialise began mapping human anatomy digitally in three dimensions, using sliced CT image data, which lead to the development of its medical image processing software: Mimics. Concurrently, the team was also developing its industrial software solution, Magics. Both of these software solutions were later commercialized to promote growth.
In 1995, Materialise became the first company to produce 3D printed parts in more than one colour, specifically at this time for anatomical models produced using the stereolithography process to delineate the complexities of the anatomy (such as nerves, blood vessels and tumours) and allow surgeons to more precisely plan for operations.
The company developed and produced the first customised 3D printed surgical guide for a dental operation in 1996. These personalised guides were utilised during surgery to show surgeons bone cutting and drilling locations to apply implants. This knowledge was used to develop Materialise SimPlant software, allowing the surgeon to virtually plan the surgery and minimize invasive exploratory surgery.
The company launched one of the first 3D printing online ordering systems in 1997, Materialise NextDay, which later became Materialise OnSite. This service allowed 3D printing service customers to send digital 3D data, which could be printed and shipped the next day.
Demand for prototypes grew, leading Materialise to develop its Mammoth Stereolithography systems, which are capable of printing single-piece models with dimensions of more than 2 meters in the Y axis.
2000s
In the year 2000, hearing aid specialist Phonak approached Materialise to develop the Rapid Shell Modeling (RSM) software. This allowed the design process for customized, patient-specific hearing aid shells to become automated. The resulting designs could then be 3D printed to produce the customised hearing aids. This was the first high volume, end-use application of 3D printing, and today, 99% of the world's hearing aids are now produced using 3D printing.
Materialise acquired US company Columbia Scientific Inc, (CSI) in 2001, the creators of Sim/Plant and ImageMaster, which became the US headquarters for Materialise's dental division in that region.
In 2003 Materialise launched one of the first 3D printed consumer brands — .MGX by Materialise — for 3D printing end-use products as well as prototypes. In parallel, the company also acquired Fused Deposition Modelling (FDM) systems for industrial applications.
The following year, in 2004, Materialise introduced its 3-matic software, allowing 3D printer users to edit files directly in the STL format. Previously, if design changes were required in the digital model, designers had to make them in the CAD suite of choice before re-converting the entire file to STL again.
In 2006 Materialise launched RapidFit, developed as a 3D printed solution for shipping large parts with customized jigs and fixtures to prevent deformation or breakage while in transit.
In 2006 Materialise developed the first Titanium 3D printed skull implants, following the acquisition of OBL, which specialized in the creation of custom cranio-maxillfacial (CMF) implants, producing customized implants with intricate porous structures, that behave like natural bone and mimic its mechanical and thermal properties.
In 2008 Materialise introduced the e-Stage software which was the first software to automatically generate support structures for different geometries in Stereolitography. In the same year, the company launched i.materialise for the consumer market, making it possible for anyone to print their ideas using professional-quality equipment. Materialise also developed its first Build Processor to support running different 3D printing processes more efficiently within a single location.
2010s
In 2012, Materialise introduced Streamics to provide traceable quality control to industrial 3D printer users producing end-use parts within regulated industries.
Materialise went public on June 25, 2014 to enable expansion of its services and software development. The same year the company acquired OrthoView, a market leader in orthopaedic digital pre-operative planning software founded by Adrian Dwyer, John Chambers, and Peter Quinn, and officially established a new office in China in December with a focus on 3D printing Software and R&D, namely Materialise Shanghai Co. Ltd.
In 2016, the company opened a new and dedicated metal production facility in Bremen, Germany. Materialise HQ, Leuven, also acquired and started testing the multi jet fusion (MJF) process from HP. Production of parts with MJF started in the following year, 2017.
With the expansion of the AM Metal market, Materialise acquired ACTech in Germany to extend the company's metal capabilities, with a specific emphasis on low-volume production of highly complex metal parts. The acquisition also enabled Materialise to develop and improve its software suite for metal 3D printing.
== References ==
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MTLS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 42.75Y avg ≈3.4 | ≈3.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MTLS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 57.1%5Y avg ≈56.7% | ≈56.7% | · | · | |
| Operating Margin | 3.3%5Y avg ≈2.8% | ≈2.8% | · | · | |
| EBITDA Margin | 11.5%5Y avg ≈4.4% | ≈4.4% | · | · | |
| Pretax Margin | 2.7%5Y avg ≈3.4% | ≈3.4% | · | · | |
| Net Profit Margin | 2.9%5Y avg ≈3.2% | ≈3.2% | · | · | |
| ROA | 1.9%5Y avg ≈2.0% | ≈2.0% | · | · | |
| ROE | 3.1%5Y avg ≈3.6% | ≈3.6% | · | · | |
| ROIC | 3.7%5Y avg ≈2.5% | ≈2.5% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MTLS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 2.45Y avg ≈2.2 | ≈2.2 | · | · | |
| Quick Ratio | 1.55Y avg ≈1.4 | ≈1.4 | · | · | |
| Interest Coverage | 5.25Y avg ≈3.9 | ≈3.9 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MTLS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.75Y avg ≈0.6 | ≈0.6 | · | · | |
| Revenue / Employee | ≈$104.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $0.07 | $0.04 | 71.6% | |
| March 31, 2026 | $0.03 | $0.01 | 194.1% | |
| Dec. 31, 2025 | $0.11 | $0.06 | 79.7% | |
| Sept. 30, 2025 | $0.04 | $0.01 | 292.2% | |
| June 30, 2025 | $0.00 | $0.02 | -100.0% | |
| Dec. 31, 2024 | $0.05 | $0.05 | -2.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $267M | $256M | $232M | $205M | $170M | $197M | $185M | $143M | $114M | |
| Cost of Revenue | $115M | $116M | $111M | $103M | $87M | $76M | $87M | $82M | $63M | $47M | |
| Gross Profit | $153M | $151M | $145M | $129M | $118M | $94M | $110M | $102M | $80M | $68M | |
| R&D Expense | $46M | $44M | $38M | $38M | $27M | $27M | $23M | $22M | $20M | $18M | |
| Operating Income | $9M | $9M | $6M | $-3M | $12M | $-5M | $7M | $5M | $392.0K | $107.0K | |
| Interest Expense | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $665.0K | |
| Interest Income | $4M | $8M | $5M | $6M | $6M | $2M | $1M | $4M | $3M | $2M | |
| Pretax Income | $7M | $14M | $7M | $-1M | $14M | $-8M | $4M | $3M | $-2M | $-1M | |
| Income Tax | $-429.0K | $733.0K | $78.0K | $975.0K | $591.0K | $-1M | $3M | $425.0K | $522.0K | $2M | |
| Net Income | $8M | $13M | $7M | $-2M | $13M | $-7M | $2M | $3M | $-2M | $-3M | |
| EPS (Basic) | $0.13 | $0.23 | $0.11 | $-0.04 | $0.23 | $-0.13 | $0.03 | $0.06 | $-0.04 | $-0.06 | |
| EPS (Diluted) | $0.13 | $0.23 | $0.11 | $-0.04 | $0.23 | $-0.13 | $0.03 | $0.06 | $-0.04 | $-0.06 | |
| Shares (Basic) | 59,067,000 | 59,067,000 | 59,067,000 | 59,064,000 | 56,685,000 | 53,364,000 | 52,915 | 49,806 | 47,325 | 47,325 | |
| Shares (Diluted) | 59,072,000 | 59,105,000 | 59,085,000 | 59,064,000 | 56,843,000 | 53,364,000 | 53,987 | 50,697 | 47,325 | 47,325 | |
| EBITDA | $31M | $9M | $6M | $-3M | $12M | $-5M | $7M | $5M | $865.0K | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $134M | $102M | $128M | $141M | $196M | $112M | $129M | $116M | $43M | $56M | |
| Inventory | · | · | $17M | $16M | $11M | $10M | $13M | $10M | $11M | $8M | |
| Current Assets | $224M | $191M | $206M | $216M | $258M | $161M | $191M | $169M | $97M | $96M | |
| PP&E (Net) | $113M | $111M | $95M | $94M | $84M | $88M | $91M | $93M | $87M | $45M | |
| Goodwill | $43M | $43M | $43M | $44M | $19M | $19M | $20M | $17M | $18M | $9M | |
| Intangibles | $26M | $30M | $31M | $38M | $32M | $33M | $27M | $26M | $29M | $10M | |
| Total Assets | $421M | $396M | $397M | $411M | $413M | $326M | $349M | $313M | $235M | $162M | |
| Current Liabilities | $92M | $102M | $105M | $106M | $91M | $84M | $84M | $73M | $63M | $48M | |
| Retained Earnings | $27M | $19M | $6M | $-1M | $965.0K | $-7M | $-272.0K | $-2M | $-4M | $-2M | |
| Stockholders' Equity | $256M | $249M | $237M | $229M | $233M | $133M | $140M | $136M | $77M | $79M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $22M | $22M | · | · | · | · | · | · | · | |
| Other Non-cash | $-4M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $25M | $31M | $20M | $22M | $26M | $30M | $28M | · | · | · | |
| CapEx | $14M | $25M | $9M | $22M | $8M | $11M | $13M | · | · | · | |
| Investing Cash Flow | $-10M | $-29M | $-11M | $-54M | $-13M | $-28M | $-26M | · | · | · | |
| Financing Cash Flow | $17M | $-28M | $-22M | $-23M | $71M | $-17M | $11M | · | · | · | |
| Free Cash Flow | $11M | $7M | $11M | $680.0K | $18M | · | · | · | · | · | |
| Levered FCF | $9M | $6M | $9M | $-3M | $16M | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.1% | 56.5% | 56.7% | 55.5% | 57.5% | 55.1% | 55.8% | 55.5% | 56.0% | · | |
| Operating Margin | 3.3% | 3.5% | 2.2% | -1.2% | 5.9% | -2.7% | 3.6% | 2.8% | 0.61% | · | |
| Net Margin | 2.9% | 5.0% | 2.6% | -0.91% | 6.4% | -4.2% | 0.84% | 1.6% | -1.2% | · | |
| Pretax Margin | 2.7% | 5.3% | 2.6% | -0.51% | 6.7% | -4.8% | 2.2% | 1.9% | -0.79% | · | |
| EBITDA Margin | 11.5% | 3.5% | 2.2% | -1.2% | 5.9% | -2.7% | 3.6% | 2.8% | 0.61% | · | |
| ROA | 1.9% | 3.4% | 1.7% | -0.51% | 3.6% | -2.1% | 0.50% | 1.1% | -0.83% | · | |
| ROE | 3.1% | 5.5% | 2.9% | -0.92% | 7.2% | -5.2% | 1.2% | 2.8% | -2.1% | · | |
| ROIC | 3.7% | 3.6% | 2.4% | -2.3% | 5.0% | -3.1% | 2.0% | 3.3% | 0.58% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 1.9 | 2.0 | 2.0 | 2.8 | 1.9 | 2.3 | 2.3 | 1.5 | · | |
| Quick Ratio | 1.5 | 1.0 | 1.2 | 1.3 | 2.1 | 1.3 | 1.5 | 1.6 | 0.7 | · | |
| Interest Coverage | 5.2 | 7.3 | 3.2 | -1.4 | 5.0 | -2.0 | 3.3 | 3.0 | -0.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | |
| Inventory Turnover | · | · | 6.7 | 7.5 | 8.2 | 6.7 | 7.7 | 7.8 | -6.5 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $4.53 | $4.51 | $4.33 | $3.93 | $3614.34 | $3194.08 | $3643.08 | $3649.96 | $3.01 | · | |
| Cash Flow / Share | $0.43 | $0.53 | $0.34 | $0.38 | $454.67 | · | · | · | · | · | |
| EPS (TTM) | $0.13 | $0.23 | $0.11 | $-0.04 | $0.23 | $-0.13 | $0.03 | $0.06 | $-0.04 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $268M | $267M | $256M | $232M | $205M | $170M | $197M | $185M | $143M | · | |
| Net Income TTM | $8M | $13M | $7M | $-2M | $13M | $-7M | $2M | $3M | $-2M | · | |
| P/E | 42.7 | 30.6 | 59.7 | -220.0 | 103.8 | -417.0 | 610.3 | 330.0 | -284.3 | · | |
| Earnings Yield | 2.3% | 3.3% | 1.7% | -0.45% | 0.96% | -0.24% | 0.16% | 0.30% | -0.35% | · |
Per Share
| Metric | Trend | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|---|---|---|
| EPS (TTM) | $0.03 | $0.06 | $-0.04 | $-0.06 | $-0.06 | · |
Valuation (TTM)
| Metric | Trend | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $197M | $185M | $143M | $114M | $102M | · | |
| Net Income TTM | $2M | $3M | $-2M | $-3M | $-3M | · | |
| P/E | 610.3 | 330.0 | -284.3 | -128.0 | -117.7 | · | |
| Earnings Yield | 0.16% | 0.30% | -0.35% | -0.78% | -0.85% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $268M | $267M | $256M | $232M | $205M |
| Gross Margin % | 57.1% | 56.5% | 56.7% | 55.5% | 57.5% |
| Operating Margin % | 3.3% | 3.5% | 2.2% | -1.2% | 5.9% |
| Net Income | $8M | $13M | $7M | $-2M | $13M |
| Diluted EPS | $0.13 | $0.23 | $0.11 | $-0.04 | $0.23 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.4 | 1.9 | 2.0 | 2.0 | 2.8 |
| Quick Ratio | 1.5 | 1.0 | 1.2 | 1.3 | 2.1 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $11M | $7M | $11M | $680.0K | $18M |
Institutional owners (13F) 66 filers · $57.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (-4 vs prior Q) | 9 (+2 vs prior Q) | 15 (-1 vs prior Q) | 23 (+2 vs prior Q) | +519K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| DISCIPLINED GROWTH INVESTORS INC /MN | $14,803,837 | 1,992,441 | 25.60% | Shares |
| Rock Point Advisors, LLC | $7,362,172 | 990,871 | 12.73% | Shares |
| Archon Capital Management LLC | $5,696,001 | 766,622 | 9.85% | Shares |
| KING LUTHER CAPITAL MANAGEMENT CORP | $4,671,613 | 628,750 | 8.08% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $3,544,006 | 476,986 | 6.13% | Shares |
| ARK Investment Management LLC | $3,118,995 | 419,784 | 5.39% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,200,766 | 296,200 | 3.81% | Shares |
| CITADEL ADVISORS LLC | $1,828,649 | 246,117 | 3.16% | Shares |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $1,486,052 | 200,007 | 2.57% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,171,711 | 157,700 | 2.03% | Put option |
| AMH Equity Ltd | $1,156,672 | 207,661 | 2.00% | Shares |
| CREDIT AGRICOLE S A | $1,120,184 | 150,765 | 1.94% | Shares |
| MORGAN STANLEY | $1,110,153 | 149,415 | 1.92% | Shares |
| UBS Group AG | $915,561 | 123,225 | 1.58% | Shares |
| TWO SIGMA INVESTMENTS, LP | $746,916 | 100,527 | 1.29% | Shares |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $743,000 | 100,000 | 1.28% | Shares |
| AXA Investment Managers S.A. | $636,250 | 114,228 | 1.10% | Shares |
| Quinn Opportunity Partners LLC | $594,422 | 80,003 | 1.03% | Shares |
| MILLENNIUM MANAGEMENT LLC | $500,069 | 67,304 | 0.86% | Shares |
| LPL Financial LLC | $371,195 | 49,959 | 0.64% | Shares |
| Trexquant Investment LP | $302,787 | 40,752 | 0.52% | Shares |
| XTX Topco Ltd | $297,475 | 40,037 | 0.51% | Shares |
| MERITAGE PORTFOLIO MANAGEMENT | $295,637 | 53,268 | 0.51% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $278,313 | 37,458 | 0.48% | Shares |
| JANE STREET GROUP, LLC | $268,810 | 36,179 | 0.46% | Shares |
| Engineers Gate Manager LP | $257,992 | 34,723 | 0.45% | Shares |
| STATE STREET CORP | $232,670 | 31,315 | 0.40% | Shares |
| TWO SIGMA ADVISERS, LP | $229,770 | 41,400 | 0.40% | Shares |
| JANE STREET GROUP, LLC | $219,928 | 29,600 | 0.38% | Call option |
| Argos Wealth Advisors, LLC | $217,090 | 29,218 | 0.38% | Shares |
| JPMORGAN CHASE & CO | $211,943 | 29,601 | 0.37% | Shares |
| NewEdge Advisors, LLC | $195,409 | 26,300 | 0.34% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $137,655 | 18,527 | 0.24% | Shares |
| AXQ CAPITAL, LP | $118,390 | 15,934 | 0.20% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $92,132 | 12,400 | 0.16% | Call option |
| Granite Investment Partners, LLC | $87,050 | 11,716 | 0.15% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $83,461 | 11,233 | 0.14% | Shares |
| QRG CAPITAL MANAGEMENT, INC. | $80,801 | 10,875 | 0.14% | Shares |
| JANE STREET GROUP, LLC | $75,786 | 10,200 | 0.13% | Put option |
| Teton Advisors, LLC | $74,300 | 10,000 | 0.13% | Shares |
| GAMMA Investing LLC | $60,748 | 8,176 | 0.11% | Shares |
| Teton Advisors, Inc. | $56,500 | 10,000 | 0.10% | Shares |
| RHUMBLINE ADVISERS | $35,319 | 4,754 | 0.06% | Shares |
| Federation des caisses Desjardins du Quebec | $26,048 | 3,508 | 0.05% | Shares |
| State of Tennessee, Department of Treasury | $25,849 | 3,479 | 0.04% | Shares |
| OSAIC HOLDINGS, INC. | $21,918 | 2,950 | 0.04% | Shares |
| BlackRock, Inc. | $15,833 | 2,131 | 0.03% | Shares |
| ROYAL BANK OF CANADA | $13,000 | 1,715 | 0.02% | Shares |
| CoreCap Advisors, LLC | $9,288 | 1,250 | 0.02% | Shares |
| SIMPLEX TRADING, LLC | $5,260 | 708 | 0.01% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Wilfried Vancraen, Hilde Ingelaere, Idem ×5 filings | Oct. 30, 2025 | 57.60% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
MTLS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
3 analysts · 2026-09-30Mean target $8.81 +3.6%
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.